Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie 07. Février 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 3757  Page précédente Page suivante
   
   Articles 1 - 20 / 75121  
   
T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy.
J Cell Mol Med
Nouri K, Asadollahei N, Haghir-Sharif-Zamini Y, Seydi H, Salehi M, Mesdaghi M, Najimi M, Vosough M.
PMID: 41645702 [PubMed - indexed for MEDLINE]


Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy.
Technol Cancer Res Treat
Zhong D, Liang Y, Su Y, Yang Q, Yan H, Huang X, Shang J.
PMID: 41642855 [PubMed - indexed for MEDLINE]


A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series.
Cancer Med
Liava C, Venkatesh S, Torbenson MS, Kamath PS, Hilscher M.
PMID: 41641648 [PubMed - indexed for MEDLINE]


Treatment-related differences in quality of life and psychological distress among patients with hepatocellular carcinoma: A cross-sectional analysis.
Palliat Support Care
Tsai YT, Lu ZT, Kuo HY, Yang YH, Tsai YJ, Tsai KF, Liu WC.
PMID: 41641613 [PubMed - indexed for MEDLINE]


Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway.
World J Gastroenterol
Tong HX, Zhang JL, Nie WY, Jiang LJ, Hu JQ, Lu T.
PMID: 41640866 [PubMed - indexed for MEDLINE]


Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials.
World J Gastroenterol
Ascari S, Chen R, De Sinno A, Stefanini B, Cescon M, Serenari M, Mosconi C, Tovoli F.
PMID: 41640611 [PubMed - indexed for MEDLINE]


Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism.
World J Gastroenterol
Cai Y, Liu LY, Xia XX, Tang H, Xu M, Sai WL, Yao DF, Yao M.
PMID: 41640606 [PubMed - indexed for MEDLINE]


Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.
Liver Int
Nakayama Y, Takeishi K, Itoh S, Motomura T, Toshima T, Yugawa K, Tomiyama T, Tsutsui Y, Toshida K, Ishikawa T, Mita J, Kurihara T, Soto-Gutierrez A, Yoshizumi T.
PMID: 41637660 [PubMed - indexed for MEDLINE]


Liver Metastases and Survival Among Patients With Colorectal Cancer.
JAMA Netw Open
Johannsen IR, Boysen AK, Nielsen MF, Mortensen FV, Kirkegård J.
PMID: 41632135 [PubMed - indexed for MEDLINE]


Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.
Ann Transplant
Na BG, Hwang S, Han J, Jung DH, Song GW, Lee YY, Tak E, Lee KJ, Kim YK.
PMID: 41630389 [PubMed - indexed for MEDLINE]


Impact of microvascular invasion on clinical outcomes in hepatocellular carcinoma patients following liver transplantation.
Medicine (Baltimore)
Yan Q, Deng J, Liu Y, Wang FJ, Chen HW.
PMID: 41630216 [PubMed - indexed for MEDLINE]


Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis.
PLoS Med
Li ZY, Li HL, Wang J, Shen QM, Zou YX, Yang DN, Tan YT, Xiang YB.
PMID: 41628182 [PubMed - indexed for MEDLINE]


The prognostic value of systemic immune-inflammation index and prognostic nutritional index for colorectal cancer cases with liver metastasis post-transcatheter arterial chemoembolization.
Future Oncol
Tan X, Wu J, Jin Z.
PMID: 41627924 [PubMed - indexed for MEDLINE]


Burden, trends and projections of liver cancer in China and G20 countries: a comparative study based on the global burden of disease database 2021.
Front Public Health
He YF, Liu YM, Ren BN, An J, Wu YP, Zhao JQ, Ma YL, He W, Wu HZ.
PMID: 41626390 [PubMed - indexed for MEDLINE]


Lactylation: the malignant playbook of hepatocellular carcinoma cells and their roadmap to therapy resistance.
Front Immunol
Li S, Lu X, Zhang L.
PMID: 41624887 [PubMed - indexed for MEDLINE]


The PLANES model for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib and PD-1 inhibitors: a multicenter, retrospective study.
Front Immunol
Ya H, Wang K, Wu J, Wu J, Zeng Z, Li Y, Ou X, Song H, Yan M, Li S.
PMID: 41624866 [PubMed - indexed for MEDLINE]


Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification.
JCO Clin Cancer Inform
Mojtahedi R, Hamghalam M, Peoples JJ, Jarnagin WR, Do RKG, Simpson AL.
PMID: 41616240 [PubMed - indexed for MEDLINE]


Isolated Hepatic Hemangiomatosis Leading to Fatal Consumptive Coagulopathy in an Elderly Patient: A Case Report.
Am J Case Rep
, Oszytko JK, Chlebowska GM.
PMID: 41615903 [PubMed - indexed for MEDLINE]


Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma.
Oncol Res
Kim HS, Son JA, Kang M, Kim SS, Baek GO, Yoon MG, Jang SH, Jung D, Han JE, Cheong JY, Eun JW.
PMID: 41613803 [PubMed - indexed for MEDLINE]


Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study.
J Med Internet Res
Liu Z, Li M, Jia Y, Chen L.
PMID: 41610421 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 75121    Page 1 de 3757  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1